The Latest Breaking News from Multiple Sclerosis

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

The British 400m runner Laviai Nielsen revealed she has multiple sclerosis while Germany’s Richard Ringer won the marathon with sprint finish

Debbie Pragt lives with multiple sclerosis and sometimes struggles to walk, let alone care for her pets. She now gets help from a dedicated pet carer, and wants to see more people benefit from the service.

The 400m hurdler took to the start line at the Commonwealth Games for the first time since revealing she had been diagnosed with relapsing remitting MS aged 17

Debbie Edwards won't let anything stop her achieving her goals - this year she's joining the Great North Run

Lina Nielsen makes her debut at the Comonwealth Games this week, and ahead of it the British athlete has bravely revealed her multiple sclerosis diagnosis

Weeks after returning to Scotland from Morocco, Linda Hoskins was diagnosed with Multiple Sclerosis (MS).

ALMOST 600 patients were diagnosed with multiple sclerosis (MS) in Scotland in 2021.

Antony Butcher reaches San Francisco after pedalling 4,000 miles from New York and raising £25,000

The FDA has placed Sanofi SA's (NASDAQ:SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold.  New enrollment in the U.S. is paused, and participants in the U.S. who have been in the trial for fewer than 60 days shall suspend the study drug.  The participants who…

Jazz Pharmaceuticals (NASDAQ: JAZZ) announced top-line results from the Phase 3 clinical trial investigating nabiximols oromucosal spray (JZP378) on clinical measures of spasticity in individuals with multiple sclerosis (MS).